Safety and Tolerability of Tolvaptan in an Autosomal Dominant Polycystic Kidney Disease Spanish Cohort: A Real-World Experience

Introduction: Autosomal dominant polycystic kidney disease (ADPKD) is the commonest inherited disorder of the kidneys. A vasopressin V2-receptor antagonist (tolvaptan) was recently approved for the treatment of ADPKD. This study aims to analyze the safety and tolerability of tolvaptan for the manage...

Descripción completa

Detalles Bibliográficos
Autores principales: Guerra-Torres, Xavier E, Peña Esparragoza, J, Perez Fernandez, M, Fernandez Rodríguez, M, Mancha Ramos, J, Martinez Miguel, P, Rodriguez Puyol, D, Bouarich, H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2020
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7532866/
https://www.ncbi.nlm.nih.gov/pubmed/33033683
http://dx.doi.org/10.7759/cureus.10207

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7532866/
https://www.ncbi.nlm.nih.gov/pubmed/33033683
http://dx.doi.org/10.7759/cureus.10207

Ejemplares similares